According to a recent 13G filing with the US Securities and Exchange Commission, Joseph Edelman‘s Perceptive Advisors has increased its stake in Versartis Inc. (NASDAQ:VSAR) to 4.03 million common shares, which account for 13.63% of the float. The stake was raised from 2.84 million shares Perceptive Advisors previously held at the end of June, according to its last 13F filing.
Versartis is a biopharmaceutical company that primarily works on producing long-acting therapeutics for treating endocrine illnesses. Over the past 12 months, the company’s stock has gained 8.41%. In its last financial report for the second quarter of 2016, Versartis disclosed a net loss of $22.1 million and a loss per share of $0.75, which compares to a net loss of $19.7 million, and a loss per share of $0.67 for the corresponding quarter in the previous year. Recently Piper Jaffray Cos. initiated coverage on Versartis’ stock and placed an ‘Overweight’ rating on it, with a price target of $22.
RAJ CREATIONZS / shutterstock.com
Six smart money managers from Insider Monkey’s database reported long positions in Versartis (NASDAQ:VSAR) at the end of June, versus seven funds in an earlier quarter. Among bullish investors were Julian Baker And Felix Baker’s Baker Bros. Advisors, with a position valued at $30.12 million, Dennis Purcell’s Aisling Capital, which held a position valued at $25.21 million, Chuck Royce’s Royce & Associates, Mark Kingdon’s Kingdon Capital Management, and D. E. Shaw’s D E Shaw. An investor who dumped Versartis (NASDAQ:VSAR) during June quarter was Israel Englander’s Millennium Management, which said goodbye to $701,000 worth of shares.
Follow Aravive Inc. (NASDAQ:ARAV)
Follow Aravive Inc. (NASDAQ:ARAV)
You can access the original SEC filing by clicking here.
Ownership Summary Table
| Name | Sole Voting Power | Shared Voting Power | Sole Dispositive Power | Shared Dispositive Power | Aggregate Amount Owned Power | Percent of Class |
|---|---|---|---|---|---|---|
| Perceptive Advisors | 0 | 4,028,685 | 0 | 4,028,685 | 13.63% | |
| Joseph Edelman | 0 | 4,028,685 | 0 | 4,028,685 | 13.63% | |
| Perceptive Life Sciences Master Fund, Ltd | 0 | 3,871,286 | 0 | 3,871,286 | 13.1% |
Follow Joseph Edelman's Perceptive Advisors
Page 1 of 8 – SEC Filing
UNITED
STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE
13G/A
Under
the Securities Exchange Act of 1934
Versartis, Inc.
(Name
of Issuer)
Common
Stock
(Title
of Class of Securities)
92529L102
(CUSIP
Number)
September
28, 2016
(Date
of Event Which Requires Filing of this Statement)
Check the
appropriate box to designate the rule pursuant to which this Schedule is filed:
| x | Rule 13d-1(b) |
| x | Rule 13d-1(c) |
| o | Rule 13d-1(d) |
*The
remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the
subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided
in a prior cover page.
The
information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section
18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the Notes).
Persons
who are to respond to the collection of information contained in this form are not required to respond unless the form displays
a currently valid OMB control number.
Follow Aravive Inc. (NASDAQ:ARAV)
Follow Aravive Inc. (NASDAQ:ARAV)
Page 2 of 8 – SEC Filing
| CUSIP No. 92529L102 | 13G/A | Page 2 of 8 Pages |
| 1. | names of reporting i.r.s. identification no.
Perceptive Advisors LLC | |||||
| 2. | check the appropriate box if a group* | (a) (b) | ||||
| 3. | sec use only
| |||||
| 4. | citizenship or place Delaware, United | |||||
| number of shares | 5. | sole voting power | 0 | |||
| beneficially owned by | 6. | shared voting power | 4,028,685 | |||
| each reporting | 7. | sole dispositive power | 0 | |||
| person with: | 8. | shared dispostive power | 4,028,685 | |||
| 9. | aggregate amount beneficially owned by each reporting person | 4,028,685 | ||||
| 10. | check box if the aggregate amount in row (9) excludes certain shares (See Instructions) | o | ||||
| 11. | percent of class represented by amount in row (9) | 13.63% | ||||
| 12. | type of reporting person (See Instructions) | IA | ||||
Follow Aravive Inc. (NASDAQ:ARAV)
Follow Aravive Inc. (NASDAQ:ARAV)
Page 3 of 8 – SEC Filing
| CUSIP No. 92529L102 | 13G/A | Page 3 of 8 Pages |
| 1. | names of reporting i.r.s. identification no.
Joseph Edelman | |||||
| 2. | check the appropriate box if a group* | (a) (b) | ||||
| 3. | sec use only
| |||||
| 4. | citizenship or place United States of America | |||||
| number of shares | 5. | sole voting power | 0 | |||
| beneficially owned by | 6. | shared voting power | 4,028,685 | |||
| each reporting | 7. | sole dispositive power | 0 | |||
| person with: | 8. | shared dispostive power | 4,028,685 | |||
| 9. | aggregate amount beneficially owned by each reporting person | 4,028,685 | ||||
| 10. | check box if the aggregate amount in row (9) excludes certain shares (See Instructions) | o | ||||
| 11. | percent of class represented by amount in row (9) | 13.63% | ||||
| 12. | type of reporting person (See Instructions) | IN | ||||
Follow Aravive Inc. (NASDAQ:ARAV)
Follow Aravive Inc. (NASDAQ:ARAV)
Page 4 of 8 – SEC Filing
| CUSIP No. 92529L102 | 13G/A | Page 4 of 8 Pages |
| 13. | names of reporting i.r.s. identification no.
Perceptive Life | |||||
| 14. | check the appropriate box if a group* | (a) (b) | ||||
| 15. | sec use only
| |||||
| 16. | citizenship or place Cayman | |||||
| number of shares | 17. | sole voting power | 0 | |||
| beneficially owned by | 18. | shared voting power | 3,871,286 | |||
| each reporting | 19. | sole dispositive power | 0 | |||
| person with: | 20. | shared dispostive power | 3,871,286 | |||
| 21. | aggregate amount beneficially owned by each reporting person | 3,871,286 | ||||
| 22. | check box if the aggregate amount in row (9) excludes certain shares (See Instructions) | o | ||||
| 23. | percent of class represented by amount in row (9) | 13.1% | ||||
| 24. | type of reporting person (See Instructions) | IN | ||||
Follow Aravive Inc. (NASDAQ:ARAV)
Follow Aravive Inc. (NASDAQ:ARAV)
Page 5 of 8 – SEC Filing
| CUSIP No. 92529L102 | 13G/A | Page 5 of 8 Pages |
| Item 1. | ||||
| (a) | Name of Issuer: | Versartis, Inc. | ||
| (b) | Address of Issuer’s Principal Executive Offices: | 4200 Bohannon Drive, Suite 250 Menlo Park, CA 94025 | ||
| Item 2. | ||||
| (a) | Name of Person Filing: | This | ||
| (b) | Address of Principal Business Office or, if none, Residence: | 51 New York, NY 10003 | ||
| (c) | Citizenship: | Perceptive | ||
| (d) | Title of Class of Securities: | Common Stock | ||
| (e) | CUSIP Number: | 01438T106 | ||
| Item 3. | If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a: |
| (a) | o | Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o). | |
| (b) | o | Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c). | |
| (c) | o | Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c). | |
| (d) | o | Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C 80a-8). | |
| (e) | x | An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E); | |
| (f) | o | An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F); | |
| (g) | o | A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G); | |
| (h) | o | A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813); | |
| (i) | o | A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3); | |
| (j) | o | Group, in accordance with §240.13d-1(b)(1)(ii)(J). |
Follow Aravive Inc. (NASDAQ:ARAV)
Follow Aravive Inc. (NASDAQ:ARAV)
Page 6 of 8 – SEC Filing
| CUSIP No. 92529L102 | 13G/A | Page 6 of 8 Pages |
| Item 4. | Ownership. |
Provide
the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in
Item 1.
| (a) | Amount beneficially owned: | Perceptive | |
| (b) | Percent of class: | Perceptive Advisors | |
| (c) | Number
Perceptive | ||
| (i) | Sole power to vote or to direct the vote: | 0 | |
| (ii) | Shared power to vote or to direct the vote: | 4,028,685 | |
| (iii) | Sole power to dispose or to direct the disposition of: | 0 | |
| (iv) | Shared power to dispose or to direct the disposition of: | 4,028,685 |
| Perceptive Life Sciences Master Fund Ltd: | |||
| (i) | Sole power to vote or to direct the vote: | 0 | |
| (ii) | Shared power to vote or to direct the vote: | 3,871,286 | |
| (iii) | Sole power to dispose or to direct the disposition of: | 0 | |
| (iv) | Shared power to dispose or to direct the disposition of: | 3,871,286 | |
| Item 5. | Ownership of Five Percent or Less of a Class. |
If
this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial
owner of more than five percent of the class of securities, check the following: o.
| Item 6. | Ownership of More Than Five Percent on Behalf of Another Person. |
The
Fund and the Account described in Item 4 have the right to receive or the power to direct the receipt of dividends from, or the
proceeds from, the sale of the securities held in its account. Filing of this statement by the Reporting Persons shall not be
deemed an admission that they beneficially own the securities reported herein. The Reporting Persons expressly disclaim beneficial
ownership of all securities reported herein.
| Item 7. | Identification and Classification of the Subsidiary which Acquired the Security Being Reported on by the Parent Holding Company or Control Person. |
Not
applicable.
Follow Aravive Inc. (NASDAQ:ARAV)
Follow Aravive Inc. (NASDAQ:ARAV)
Page 7 of 8 – SEC Filing
| CUSIP No. 92529L102 | 13G/A | Page 7 of 8 Pages |
| Item 8. | Identification and Classification of Members of the Group. |
Not
applicable.
| Item 9. | Notice of Dissolution of Group. |
Not
applicable.
| Item 10. | Certification. |
| (a) | The By |
| (b) | The By |
| The following certification shall be included if the statement is filed pursuant to §240.13d-1(c) with respect to Perceptive Life Sciences Master Fund Ltd: | |
| (c) | By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. x |
Follow Aravive Inc. (NASDAQ:ARAV)
Follow Aravive Inc. (NASDAQ:ARAV)
Page 8 of 8 – SEC Filing
| CUSIP No. 92529L102 | 13G/A | Page 8 of 8 Pages |
SIGNATURE
After
reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true,
complete and correct.
| October | ||
| Date | ||
| PERCEPTIVE ADVISORS LLC | ||
| /s/ Joseph Edelman | ||
| Signature | ||
| Joseph Edelman/Managing Member | ||
| Name/Title | ||
| October | ||
| Date | ||
| /s/ Joseph Edelman | ||
| Signature | ||
| Joseph Edelman | ||
| Name/Title | ||
| October | ||
| Date | ||
| PERCEPTIVE LIFE SCIENCES MASTER FUND LTD | ||
| By: Perceptive Advisors LLC | ||
| /s/ Joseph Edelman | ||
| Signature | ||
| Joseph Edelman/Managing Member | ||
| Name/Title | ||
The
original statement shall be signed by each person on whose behalf the statement is filed or his authorized representative. If
the statement is signed on behalf of a person by his authorized representative other than an executive officer or general partner
of the filing person, evidence of the representative’s authority to sign on behalf of such person shall be filed with the
statement, provided, however, that a power of attorney for this purpose which is already on file with the Commission may be incorporated
by reference. The name and any title of each person who signs the statement shall be typed or printed beneath his signature.
NOTE:
Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See
§240.13d-7 for other parties for whom copies are to be sent.
| Attention: | Intentional misstatements or omissions of fact constitute Federal criminal violations (See 18 U.S.C. 1001) |
